Avineuro develops its research platform through strategic partnerships with highly acclaimed medical research institutions and reputable contract research organizations. Our business strategy involves in-licensing of clinically enabled compounds, partnering with pharma and biotech companies for co-development and other forms of collaboration.

OUR PARTNERSHIPS

CHEMDIV, INC.

Avineuro holds an exclusive licensing agreement with ChemDiv for drug candidates for treatment of multiple psychiatric and neurological indications.

IPHARMA LLC

IPHARMA LLC is a clinical CRO at ChemRar/ChemDiv group of companies focusing on Phase 1, Phase 2, Phase 3, Translational, POC, Registration, Viral infections, Russia, Oncology, Endocrinology, Cardiovascular, Autoimmune disease, Psychiatry, Neurology, Bioequivalence, Biosimilars. http://www.ipharma.ru